Folgen
Eric Simpson
Eric Simpson
Frances J. Storrs Medical Dermatology Professor, Dermatology, OHSU
Bestätigte E-Mail-Adresse bei ohsu.edu - Startseite
Titel
Zitiert von
Zitiert von
Jahr
Two phase 3 trials of dupilumab versus placebo in atopic dermatitis
EL Simpson, T Bieber, E Guttman-Yassky, LA Beck, A Blauvelt, MJ Cork, ...
New England Journal of Medicine 375 (24), 2335-2348, 2016
18112016
Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies
LF Eichenfield, WL Tom, TG Berger, A Krol, AS Paller, ...
Journal of the American Academy of Dermatology 71 (1), 116-132, 2014
15872014
Dupilumab treatment in adults with moderate-to-severe atopic dermatitis
LA Beck, D Thaçi, JD Hamilton, NM Graham, T Bieber, R Rocklin, JE Ming, ...
New England Journal of Medicine 371 (2), 130-139, 2014
14882014
Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis
LF Eichenfield, WL Tom, SL Chamlin, SR Feldman, JM Hanifin, ...
Journal of the American Academy of Dermatology 70 (2), 338-351, 2014
14452014
Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded …
A Blauvelt, M de Bruin-Weller, M Gooderham, JC Cather, J Weisman, ...
The Lancet 389 (10086), 2287-2303, 2017
12082017
Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents
R Sidbury, DM Davis, DE Cohen, KM Cordoro, TG Berger, JN Bergman, ...
Journal of the American Academy of Dermatology 71 (2), 327-349, 2014
1208*2014
Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention
EL Simpson, JR Chalmers, JM Hanifin, KS Thomas, MJ Cork, ...
Journal of Allergy and Clinical Immunology 134 (4), 818-823, 2014
8842014
Eczema prevalence in the United States: data from the 2003 National Survey of Children's Health
TE Shaw, GP Currie, CW Koudelka, EL Simpson
Journal of Investigative Dermatology 131 (1), 67-73, 2011
8832011
Epidemiology of atopic dermatitis in adults: results from an international survey
S Barbarot, S Auziere, A Gadkari, G Girolomoni, L Puig, EL Simpson, ...
Allergy 73 (6), 1284-1293, 2018
8082018
Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose …
D Thaci, EL Simpson, LA Beck, T Bieber, A Blauvelt, K Papp, W Soong, ...
The Lancet 387 (10013), 40-52, 2016
6342016
Anti–interleukin-31 receptor A antibody for atopic dermatitis
T Ruzicka, JM Hanifin, M Furue, G Pulka, I Mlynarczyk, A Wollenberg, ...
New England Journal of Medicine 376 (9), 826-835, 2017
6052017
Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults
AS Paller, WL Tom, MG Lebwohl, RL Blumenthal, M Boguniewicz, ...
Journal of the American Academy of Dermatology 75 (3), 494-503. e6, 2016
5642016
Patient burden and quality of life in atopic dermatitis in US adults: a population-based cross-sectional study
JI Silverberg, JM Gelfand, DJ Margolis, M Boguniewicz, L Fonacier, ...
Annals of Allergy, Asthma & Immunology 121 (3), 340-347, 2018
5612018
Mental health comorbidity in patients with atopic dermatitis
P Yaghmaie, CW Koudelka, EL Simpson
Journal of Allergy and Clinical Immunology 131 (2), 428-433, 2013
5492013
Tralokinumab for moderate‐to‐severe atopic dermatitis: results from two 52‐week, randomized, double‐blind, multicentre, placebo‐controlled phase III trials (ECZTRA 1 and ECZTRA 2)
A Wollenberg, A Blauvelt, E Guttman‐Yassky, M Worm, C Lynde, ...
British Journal of Dermatology 184 (3), 437-449, 2021
4572021
Efficacy and safety of dupilumab in adolescents with uncontrolled moderate to severe atopic dermatitis: a phase 3 randomized clinical trial
EL Simpson, AS Paller, EC Siegfried, M Boguniewicz, L Sher, ...
JAMA dermatology 156 (1), 44-56, 2020
4302020
Baricitinib in patients with moderate‐to‐severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials
EL Simpson, JP Lacour, L Spelman, R Galimberti, LF Eichenfield, ...
British Journal of Dermatology 183 (2), 242-255, 2020
4082020
Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo …
EL Simpson, R Sinclair, S Forman, A Wollenberg, R Aschoff, M Cork, ...
The Lancet 396 (10246), 255-266, 2020
3952020
Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double …
E Guttman-Yassky, HD Teixeira, EL Simpson, KA Papp, AL Pangan, ...
The Lancet 397 (10290), 2151-2168, 2021
3882021
Conjunctivitis in dupilumab clinical trials
B Akinlade, E Guttman‐Yassky, M de Bruin‐Weller, EL Simpson, ...
British Journal of Dermatology 181 (3), 459-473, 2019
3882019
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20